AR012964A1 - Compuetos derivados de bencimidazol, composiciones farmaceuticas que los contienen y su uso en la manufactura de medicamentos para tratar infeccionesvirales - Google Patents
Compuetos derivados de bencimidazol, composiciones farmaceuticas que los contienen y su uso en la manufactura de medicamentos para tratar infeccionesviralesInfo
- Publication number
- AR012964A1 AR012964A1 ARP980102756A ARP980102756A AR012964A1 AR 012964 A1 AR012964 A1 AR 012964A1 AR P980102756 A ARP980102756 A AR P980102756A AR P980102756 A ARP980102756 A AR P980102756A AR 012964 A1 AR012964 A1 AR 012964A1
- Authority
- AR
- Argentina
- Prior art keywords
- 8alkyl
- hydrogen
- alkyl
- halo
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen a ciertos derivados de bencimidazol y su uso en la preparacion de medicamentos para la terapia médica, particularmente para el tratamiento oprofilaxis de infecciones virales tal como aquellas provocadas por el virus del herpes. Se describe a la preparacion de los derivados de bencimidazol yformulaciones farmacéuticas que los contienen. En particular, se proporciona compuestos de la formula (I) en donde Z es un sustituyente de la formula (Ia),(Ib) o (Ic) y R1 es halogeno hidroxi,azido, C1-8 alquilo, C1-8alcoxi, C2-6alquenilo, C2-6alquinilo, C6-14arilC2-6alquenilo, C6-14arilC2-6alquinilo,o -NR19R20 (en donde R19 y R20 pueden ser los mismos o diferentes y son hidrogeno, C1-8alquilo, cianoC1-8alquilo, hidroxiC1-8alquilo, haloC1-8alquilo,C3-7cicloalquilo, C1-8alquilC3-7cicloalquilo, C2-6alquenilo, C3-7cicloalquilC1-8alquilo, C2-6alquinilo, C6-14arilo, C6-14arilC1-6alquilo,heterocicloC1-8alquilo, C1-8alquilcarbonilo, C6-14arilsulfonilo, oR19 R20 junto con el átomo N al cual están unidos forman un anillo heterocíclico de 3,4, 5 o 6 miembros, OR21 (donde R21 es hidrogeno, C1-8alquilo, C3-7cicloalquilo , o C6-14arilo), o SR22 (en donde R22 es hidrogeno, C1-8 alquilo, hidroxi C1-8alquilo, C3-7 cicloalquilo, o C6-14 arilo); R2 es hidrogeno o halogeno; R3 y R4 pueden ser los mismos o diferentes y hidrogeno, halogeno, C1-8alquilo, C6-14arilo, heterociclo C6-14 arilo, C1-8 alcoxi, halo C1-8 alquilo o -SR24 (en donde R24 eshidrogeno, C1-8 alquilo, C6-14 arilo, o C6-14 aril C1-8 alquilo);R5 es hidrogeno, C1-8 alquilo, halo C1-8 alquilo o C1-8 alcoxi; R6 es hidrogeno, C1-8 alquilo, hidroxi C1-8 alquilo, halo C1-8 alquilo o C1-8alcoxi; R7 es hidrogeno, hidroxi,halogeno, C1-8 alquilo, hidroxi C1-8 alquilo, halo C1-8 alquilo, C1-8 alcoxi, o R6 y R7 forman conjuntamente una ceonta o
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9711982.0A GB9711982D0 (en) | 1997-06-10 | 1997-06-10 | Benzimidazole derivatives |
GBGB9714552.8A GB9714552D0 (en) | 1997-07-11 | 1997-07-11 | Benzimidazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AR012964A1 true AR012964A1 (es) | 2000-11-22 |
Family
ID=26311687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980102756A AR012964A1 (es) | 1997-06-10 | 1998-06-10 | Compuetos derivados de bencimidazol, composiciones farmaceuticas que los contienen y su uso en la manufactura de medicamentos para tratar infeccionesvirales |
Country Status (35)
Country | Link |
---|---|
US (1) | US6455507B1 (es) |
EP (1) | EP0994890B1 (es) |
JP (1) | JP4548866B2 (es) |
KR (1) | KR20010020465A (es) |
CN (1) | CN1265665A (es) |
AP (1) | AP1262A (es) |
AR (1) | AR012964A1 (es) |
AT (1) | ATE246700T1 (es) |
AU (1) | AU740792C (es) |
BR (1) | BR9810745A (es) |
CA (1) | CA2293470C (es) |
CO (1) | CO4970737A1 (es) |
DE (1) | DE69816992T2 (es) |
DK (1) | DK0994890T3 (es) |
EA (1) | EA002305B1 (es) |
EE (1) | EE9900564A (es) |
ES (1) | ES2205527T3 (es) |
HK (1) | HK1024921A1 (es) |
HR (1) | HRP980303B1 (es) |
HU (1) | HUP0002224A3 (es) |
ID (1) | ID24054A (es) |
IL (1) | IL133285A0 (es) |
IS (1) | IS5285A (es) |
MA (1) | MA26504A1 (es) |
MY (1) | MY132872A (es) |
NO (1) | NO314847B1 (es) |
NZ (1) | NZ501415A (es) |
OA (1) | OA11230A (es) |
PE (1) | PE84099A1 (es) |
PL (1) | PL337773A1 (es) |
PT (1) | PT994890E (es) |
SK (1) | SK171499A3 (es) |
TR (1) | TR199903053T2 (es) |
TW (1) | TW565566B (es) |
WO (1) | WO1998056761A2 (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2253297A (en) | 1996-01-23 | 1997-08-20 | Regents Of The University Of Michigan, The | Imidazo{1,2-a}pyridine c-nucleosides as antiviral agents |
PL338454A1 (en) | 1997-07-30 | 2000-11-06 | Univ Michigan | Lixofuranosilbenzimidazoles as antiviral agents |
DE19741715A1 (de) * | 1997-09-22 | 1999-03-25 | Hoechst Ag | Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung |
GB0008939D0 (en) * | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
WO2002072090A1 (en) | 2001-03-12 | 2002-09-19 | Avanir Pharmaceuticals | Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
TWI276631B (en) | 2002-09-12 | 2007-03-21 | Avanir Pharmaceuticals | Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
AU2003270426A1 (en) | 2002-09-12 | 2004-04-30 | Avanir Pharmaceuticals | PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
EP1679966A4 (en) * | 2003-08-01 | 2009-05-27 | Janssen Pharmaceutica Nv | BENZIMIDAZOLE-, BENZTRIAZOLE- AND BENZIMIDAZOLONE-SUBSTITUTED O-GLUCOSIDES |
US20110070192A1 (en) * | 2003-11-14 | 2011-03-24 | Bruno Tse | Method of preparation of novel nucleoside analogs and uses |
EP1856123B1 (en) * | 2005-02-22 | 2016-02-17 | The Regents Of The University Of Michigan | Small molecule inhibitors of mdm2 and uses thereof |
DE102005019549A1 (de) * | 2005-04-25 | 2006-12-14 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Diaminobenzimidazol |
EP2545923A1 (en) * | 2005-12-22 | 2013-01-16 | Alchemia Limited | Antibacterial agents |
USRE46372E1 (en) | 2006-01-19 | 2017-04-25 | The Regents Of The Univerity Of Michigan | Method for treating hearing loss |
US9919008B2 (en) | 2006-01-19 | 2018-03-20 | The Regents Of The University Of Michigan | Method for treating age-related hearing loss (ARHL) |
US8338397B2 (en) | 2006-01-19 | 2012-12-25 | The Regents Of The University Of Michigan | Composition and method of treating side effects from antibiotic treatment |
US10238599B2 (en) | 2006-01-19 | 2019-03-26 | The Regents Of The University Of Michigan | Composition and method for treating congenital cytomegalovirus induced hearing loss |
US9770433B2 (en) | 2006-01-19 | 2017-09-26 | The Regents Of The University Of Michigan | Composition and method for treating tinnitus |
US8927528B2 (en) | 2006-01-19 | 2015-01-06 | The Regents Of The University Of Michigan | Composition for treating hearing loss |
US9889156B2 (en) | 2006-01-19 | 2018-02-13 | The Regents Of The University Of Michigan | Method for treating noise-induced hearing loss (NIHL) |
US7951845B2 (en) | 2006-01-19 | 2011-05-31 | The Regents Of The University Of Michigan | Composition and method of treating hearing loss |
AU2008286771B2 (en) * | 2007-08-15 | 2013-08-15 | Isis Pharmaceuticals, Inc. | Tetrahydropyran nucleic acid analogs |
WO2009100045A1 (en) * | 2008-02-04 | 2009-08-13 | Translational Genomics Research Institute | Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives |
WO2009100320A2 (en) | 2008-02-07 | 2009-08-13 | Isis Pharmaceuticals, Inc. | Bicyclic cyclohexitol nucleic acid analogs |
MX2011003239A (es) | 2008-09-26 | 2011-04-28 | Merck Sharp & Dohme | Nuevos derivados de bencimidazol ciclicos utiles como agentes anti-diabeticos. |
WO2010047982A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
JP2012507530A (ja) | 2008-10-29 | 2012-03-29 | メルク・シャープ・エンド・ドーム・コーポレイション | 有用な抗糖尿病剤である新規な環状ベンズイミダゾール誘導体 |
JP5557845B2 (ja) | 2008-10-31 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体 |
US8536320B2 (en) | 2009-02-06 | 2013-09-17 | Isis Pharmaceuticals, Inc. | Tetrahydropyran nucleic acid analogs |
EP2393825A2 (en) | 2009-02-06 | 2011-12-14 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and methods |
EP2538784B1 (en) | 2010-02-25 | 2015-09-09 | Merck Sharp & Dohme Corp. | Benzimidazole derivatives useful anti-diabetic agents |
CN103154014B (zh) | 2010-04-28 | 2015-03-25 | Isis制药公司 | 修饰核苷、其类似物以及由它们制备的寡聚化合物 |
US8546344B2 (en) | 2010-10-28 | 2013-10-01 | Viropharma Incorporated | Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole |
US9382294B2 (en) | 2013-03-01 | 2016-07-05 | Los Alamos National Security, Llc | Broad spectrum antibiotic compounds and use thereof |
EP3137476B1 (en) | 2014-04-28 | 2019-10-09 | Ionis Pharmaceuticals, Inc. | Linkage modified oligomeric compounds |
US10077242B2 (en) * | 2014-12-01 | 2018-09-18 | Virginia Commonwealth University | Convergent approach to the total synthesis of telmisartan via a suzuki cross-coupling reaction |
RU2629670C2 (ru) * | 2016-08-04 | 2017-08-31 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | 2-Амино-5,6-дифтор-1-(бета-D-рибофуранозил)-бензимидазол, способ получения и противовирусная активность его в отношении вируса герпеса простого 1-го типа |
KR102583547B1 (ko) | 2020-03-30 | 2023-10-06 | (주)바이오메트릭스 테크놀로지 | 신규한 벤지미다졸 유도체, 이의 제조방법 및 이의 항암제 용도 |
EP3907230A1 (en) | 2020-03-30 | 2021-11-10 | Biometrix Technology Inc. | Novel benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same |
KR102449266B1 (ko) | 2020-06-23 | 2022-09-30 | (주)바이오메트릭스 테크놀로지 | 항암 활성 그리고 항바이러스 활성을 갖는 신규한 벤지미다졸-탄수화물 결합체 화합물(Benzimidazole carbohydrate conjugate compound) 및 이의 제조 방법 |
US20210395289A1 (en) * | 2020-06-23 | 2021-12-23 | Biometrix Technology Inc | Novel benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent or anti-virus agent comprising the same |
KR102342313B1 (ko) | 2021-08-27 | 2021-12-24 | (주)바이오메트릭스 테크놀로지 | 벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1491244A (fr) | 1966-03-09 | 1967-08-11 | Nouveaux benzimidazoles solubles | |
FR1476350A (fr) | 1966-04-18 | 1967-04-07 | Yale & Towne G M B H | Ferme-porte automatique à frein |
US3655901A (en) | 1970-07-30 | 1972-04-11 | Merck & Co Inc | Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles |
DE2130030A1 (de) | 1971-06-18 | 1972-12-21 | Bayer Ag | Fungizide und bakterizide Mittel |
ES482789A0 (es) | 1978-08-25 | 1980-12-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona |
DK405988A (da) | 1987-07-29 | 1989-01-30 | Hoffmann La Roche | Benzimidazolderivater |
IT1226100B (it) | 1988-07-07 | 1990-12-10 | Dompe Farmaceutici Spa | Derivati benzimidazolici farmacologicamente attivi. |
US5248672A (en) * | 1990-11-01 | 1993-09-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazole nucleosides as antiviral agents |
ZA923641B (en) | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
EP0521463A3 (en) | 1991-07-04 | 1993-04-14 | Hoechst Aktiengesellschaft | Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents |
GB9205071D0 (en) | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
WO1994008456A1 (en) | 1992-10-21 | 1994-04-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazoles as antiviral agents |
US5399580A (en) | 1993-03-08 | 1995-03-21 | Burroughs Wellcome Co. | Therapeutic nucleosides-uses |
GB9413724D0 (en) | 1994-07-07 | 1994-08-24 | Wellcome Found | Therapeutic nucleosides |
-
1998
- 1998-06-08 HU HU0002224A patent/HUP0002224A3/hu unknown
- 1998-06-08 AT AT98936306T patent/ATE246700T1/de not_active IP Right Cessation
- 1998-06-08 KR KR1019997011599A patent/KR20010020465A/ko not_active Application Discontinuation
- 1998-06-08 CA CA002293470A patent/CA2293470C/en not_active Expired - Lifetime
- 1998-06-08 JP JP50153899A patent/JP4548866B2/ja not_active Expired - Lifetime
- 1998-06-08 MA MA25102A patent/MA26504A1/fr unknown
- 1998-06-08 IL IL13328598A patent/IL133285A0/xx unknown
- 1998-06-08 ES ES98936306T patent/ES2205527T3/es not_active Expired - Lifetime
- 1998-06-08 CN CN98807910A patent/CN1265665A/zh active Pending
- 1998-06-08 TR TR1999/03053T patent/TR199903053T2/xx unknown
- 1998-06-08 AU AU85360/98A patent/AU740792C/en not_active Ceased
- 1998-06-08 EA EA199901031A patent/EA002305B1/ru not_active IP Right Cessation
- 1998-06-08 ID IDW20000038A patent/ID24054A/id unknown
- 1998-06-08 PT PT98936306T patent/PT994890E/pt unknown
- 1998-06-08 BR BR9810745-3A patent/BR9810745A/pt not_active IP Right Cessation
- 1998-06-08 EE EEP199900564A patent/EE9900564A/xx unknown
- 1998-06-08 DK DK98936306T patent/DK0994890T3/da active
- 1998-06-08 NZ NZ501415A patent/NZ501415A/en unknown
- 1998-06-08 SK SK1714-99A patent/SK171499A3/sk unknown
- 1998-06-08 WO PCT/EP1998/003380 patent/WO1998056761A2/en not_active Application Discontinuation
- 1998-06-08 PL PL98337773A patent/PL337773A1/xx unknown
- 1998-06-08 DE DE69816992T patent/DE69816992T2/de not_active Expired - Lifetime
- 1998-06-08 EP EP98936306A patent/EP0994890B1/en not_active Expired - Lifetime
- 1998-06-08 AP APAP/P/1999/001707A patent/AP1262A/en active
- 1998-06-08 US US09/424,934 patent/US6455507B1/en not_active Expired - Lifetime
- 1998-06-09 TW TW087109162A patent/TW565566B/zh not_active IP Right Cessation
- 1998-06-09 PE PE1998000488A patent/PE84099A1/es not_active Application Discontinuation
- 1998-06-09 HR HR980303A patent/HRP980303B1/xx not_active IP Right Cessation
- 1998-06-09 MY MYPI98002560A patent/MY132872A/en unknown
- 1998-06-09 CO CO98032828A patent/CO4970737A1/es unknown
- 1998-06-10 AR ARP980102756A patent/AR012964A1/es not_active Application Discontinuation
-
1999
- 1999-12-06 IS IS5285A patent/IS5285A/is unknown
- 1999-12-09 NO NO19996086A patent/NO314847B1/no not_active IP Right Cessation
- 1999-12-09 OA OA9900275A patent/OA11230A/en unknown
-
2000
- 2000-05-18 HK HK00102973A patent/HK1024921A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR012964A1 (es) | Compuetos derivados de bencimidazol, composiciones farmaceuticas que los contienen y su uso en la manufactura de medicamentos para tratar infeccionesvirales | |
TW200626148A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
DE68921760D1 (de) | Behandlung von beschädigtem knochenmark und dosierungseinheiten dafür. | |
TW200626592A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
MX2007003327A (es) | Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa. | |
TW200626139A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
KR880005092A (ko) | 항궤양제로서 유효한 벤즈이미다졸의 신규 유도체 | |
ATE73815T1 (de) | Adenosin-derivate und pharmazeutische zusammenstellungen, welche diese als aktiven bestandteil enthalten. | |
BR0015605A (pt) | Composição e uso | |
TW200626155A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
AR019305A1 (es) | Hiv y tratamiento viral. | |
AR043367A2 (es) | Derivados de benzofenona, composiciones farmaceuticas y procesos de preparacion. | |
NO20061839L (no) | Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav | |
NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
UY25857A1 (es) | 4-alquenil (y alquinil) oxindoles los cuales inhiben las quinasas dependientes de ciclina (cdks) | |
BR9910179A (pt) | Composto, composição farmacêutica, uso de um composto, e, processo para tratar uma doença ou condição mediada por fator xa em um animal de sangue quente | |
NO20072089L (no) | Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav | |
DE69312567D1 (de) | 2-Formylpyridin-Thiosemicarbazonderivate, ihre Herstellung und ihre Verwendung als Antitumor Mittel | |
ES2177543T3 (es) | Metodo para reducir la presion intraocular en el ojo de mamiferos por administracion de antagonistas muscarinicos. | |
AR042547A1 (es) | Uso de acidos alfa - feniltiocaboxilico y alfa - feniloxicarboxilico con actividad disminuidora de la glucosa en el suero y de los lipidos en el suero | |
DE69828516D1 (de) | (hetero)aryl-sulfonamid derivate, deren herstellung und deren verwenddung als faktor xa inhibitoren | |
KR880007462A (ko) | 빈뇨치료용 프로피오페논 유도체 | |
AR032598A1 (es) | Oxazinquinolonas, una composicion farmaceutica y el uso de las mismas para preparar un medicamento utiles en el tratamiento de infecciones virales | |
BR0318533A (pt) | azolidinacarbonitrilas e seu uso como inibidores de dpp-iv | |
AR030016A1 (es) | Derivados de 4-oxo-3,5-dihidro-4h-piridazino [4,5-b]indol-1-carboxamida, medicamento y composicion farmaceutica que comprenden a dichos derivados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |